| RS2140669923 |
SLC12A6
|
Health Risk |
Likely pathogenic |
— |
| RS2140670011 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2140670185 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2140670271 |
INF2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS2140671935 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate E, Focal segmental glomerulosclerosis 5 |
| RS2140679963 |
GABRB3
|
Health Risk |
Likely pathogenic |
Epilepsy, childhood absence |
| RS2140680984 |
SMAD6
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2140681185 |
SMAD6
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Heart |
| RS2140681497 |
SMAD6
|
Health Risk |
Pathogenic |
Radioulnar synostosis, Radioulnar synostosis |
| RS2140681546 |
SMAD6
|
Health Risk |
Likely pathogenic |
Radioulnar synostosis, nonsyndromic |
| RS2140681839 |
SMAD6
|
Health Risk |
Pathogenic |
Polydactyly, Radioulnar synostosis |
| RS2140682156 |
SLC12A6
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, axonal |
| RS2140682314 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2140682397 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2140682882 |
MAP2K1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Melorheostosis |
| RS2140692680 |
AFG2B
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2140693094 |
SLC12A6
|
Health Risk |
Likely pathogenic |
Peripheral neuropathy, Peripheral neuropathy |
| RS2140693876 |
SLC12A6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peripheral neuropathy, Charcot-Marie-Tooth disease |
| RS2140696722 |
GABRB3
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 43 |
| RS2140696739 |
GABRB3
|
Health Risk |
Likely pathogenic |
— |
| RS2140701678 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS2140704811 |
OCA2
|
Health Risk |
Likely pathogenic |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS2140706418 |
OCA2
|
Health Risk |
Likely pathogenic |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS2140706563 |
KIAA0586
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS2140707466 |
KIAA0586
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS2140711733 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS2140711798 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2140711857 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2140711872 |
MAGEL2
|
Health Risk |
Likely pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS2140712808 |
MAGEL2
|
Health Risk |
Pathogenic |
— |
| RS2140713056 |
MAGEL2
|
Health Risk |
Pathogenic |
Prader-Willi syndrome, Prader-Willi syndrome |
| RS2140713406 |
MAGEL2
|
Health Risk |
Likely pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS2140714112 |
MAGEL2
|
Health Risk |
Pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS2140714188 |
MAGEL2
|
Health Risk |
Pathogenic |
— |
| RS2140714298 |
MAGEL2
|
Health Risk |
Pathogenic |
Prader-Willi syndrome, Prader-Willi syndrome |
| RS2140714531 |
MAGEL2
|
Health Risk |
Pathogenic |
— |
| RS2140714880 |
MAGEL2
|
Health Risk |
Pathogenic |
— |
| RS2140714912 |
MAGEL2
|
Health Risk |
Pathogenic |
— |
| RS2140715275 |
MAGEL2
|
Health Risk |
Likely pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS2140717041 |
MAGEL2
|
Health Risk |
Likely pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS2140717155 |
MAGEL2
|
Health Risk |
Likely pathogenic |
— |
| RS2140717169 |
MAGEL2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2140717180 |
MAGEL2
|
Health Risk |
Likely pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS2140717963 |
FBN1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2140718078 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Marfan syndrome |
| RS2140718089 |
MAGEL2
|
Health Risk |
Likely pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS2140718246 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2140718451 |
MAGEL2
|
Health Risk |
Likely pathogenic |
— |
| RS2140719261 |
MAGEL2
|
Health Risk |
Likely pathogenic |
Developmental disorder, Schaaf-Yang syndrome |
| RS2140721648 |
AFG2B
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2140724562 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2140724680 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2140726249 |
SLC12A6
|
Health Risk |
Likely pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS2140726371 |
ZMYM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, Congenital anomaly of kidney and urinary tract |
| RS2140727029 |
ZMYM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, ZMYM2-related disorder |
| RS2140733940 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2140734026 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2140734972 |
SLC12A6
|
Health Risk |
Likely pathogenic |
— |
| RS2140737430 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2140737436 |
FBN1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2140737496 |
FBN1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2140737589 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2140737885 |
GABRB3
|
Health Risk |
Pathogenic |
Epilepsy, childhood absence |
| RS2140740334 |
SLC24A5
|
Health Risk |
Likely pathogenic |
— |
| RS2140749622 |
PACS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 66 |
| RS2140754731 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS2140756412 |
SLC12A6
|
Health Risk |
Likely pathogenic |
— |
| RS2140757755 |
TTBK2
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 11, Spinocerebellar ataxia type 11 |
| RS2140763302 |
KIAA0586
|
Health Risk |
Likely pathogenic |
KIAA0586-related disorder, KIAA0586-related disorder |
| RS2140768125 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS2140770415 |
TTBK2
|
Health Risk |
Pathogenic |
— |
| RS2140777563 |
ZMYM2
|
Health Risk |
Pathogenic |
Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities |
| RS2140777637 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2140778033 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2140787387 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated thoracic aortic aneurysm, Marfan syndrome |
| RS2140787712 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
8 conditions, Marfan syndrome |
| RS2140787769 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections, Familial thoracic aortic aneurysm and aortic dissection |
| RS2140787904 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS2140799679 |
DPYS
|
Health Risk |
Pathogenic |
— |
| RS2140807775 |
ALG11;LOC130009841
|
Health Risk |
Likely pathogenic |
ALG11-congenital disorder of glycosylation, ALG11-congenital disorder of glycosylation |
| RS2140824287 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2140828534 |
ADSS1
|
Health Risk |
Pathogenic |
— |
| RS2140833479 |
ADSS1
|
Health Risk |
Likely pathogenic |
— |
| RS2140840645 |
ALG11
|
Health Risk |
Likely pathogenic |
ALG11-congenital disorder of glycosylation, ALG11-congenital disorder of glycosylation |
| RS2140844892 |
KIAA0586
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS2140845247 |
GPR68
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS2140850308 |
ZMYM2
|
Health Risk |
Likely pathogenic |
— |
| RS2140851633 |
ZMYM2
|
Health Risk |
Pathogenic |
— |
| RS2140853464 |
MADD
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type |
| RS2140861869 |
AP4E1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140861877 |
AP4E1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 51, Hereditary spastic paraplegia 51 |
| RS2140862092 |
AP4E1
|
Health Risk |
Likely pathogenic |
— |
| RS2140867780 |
VPS13C
|
Health Risk |
Likely pathogenic |
Autosomal recessive early-onset Parkinson disease 23, Autosomal recessive early-onset Parkinson disease 23 |
| RS2140873364 |
KIAA0586
|
Health Risk |
Likely pathogenic |
Joubert syndrome 23, Joubert syndrome 23 |
| RS2140873534 |
KIAA0586
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS2140875089 |
NUSAP1
|
Health Risk |
Likely pathogenic |
Microcephaly, seizures |
| RS2140875258 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS2140875758 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2140878481 |
AP4E1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2140878554 |
BUB1B
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 1, Mosaic variegated aneuploidy syndrome 1 |